来自于加拿大蒙特利尔McGill大学健康中心的Jacques Genest博士及其同事报道说,氨氯地平联用阿伐他汀治疗可使多数冠心病患者达到所建议的血脂和血压目标水平。 Genest博士等人对氨氯地平和阿伐他汀治疗134例稳定的冠心病患者的作用效果进行了分析;受试患者的血压被充分控制,但需用他汀类药物降低LDL胆固醇水平。所有患者均使用3个月的阿伐 Jacques Genest, Ph.D., of McGill University Health Center, Montreal, Canada, and colleagues report that amlodipine plus atorvastatin can reach most of the recommended lipid and blood pressure targets for patients with coronary heart disease. Dr. Genest et al. Analyzed the effects of amlodipine and atorvastatin on 134 stable patients with coronary artery disease; the blood pressure of the patients under test was well controlled but statins were used to lower LDL cholesterol levels. All patients were treated with 3 months of Alvarion